These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 485704)

  • 1. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of apontaneously hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):166-76. PubMed ID: 666457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of renal hypertensive rats.
    Kubo T; Hashimoto M; Ohashi T
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):270-8. PubMed ID: 708153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular reactivity of rats after prevention of hypertension by central administration of 6-hydroxydopamine.
    Haeusler G
    J Hypertens Suppl; 1984 Dec; 2(3):S73-5. PubMed ID: 6443713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats.
    Szadowska A; Szmigielska H; Szmigielski A; Kamińska A; Wejman I
    Pol J Pharmacol Pharm; 1985; 37(4):487-93. PubMed ID: 3936030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.
    Lamprecht F; Richardson JS; Williams RB; Kopin IJ
    J Neural Transm; 1977; 40(2):149-58. PubMed ID: 323422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine.
    Finch L; Haeusler G; Thoenen H
    Br J Pharmacol; 1972 Feb; 44(2):356P-357P. PubMed ID: 4148920
    [No Abstract]   [Full Text] [Related]  

  • 12. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central adrenergic neurons in DOCA-salt hypertension.
    Lamprecht F; Jacobowitz DM; Richardson JS; Kopin IJ
    J Neurosci Res; 1975; 1(3-4):227-34. PubMed ID: 1225988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 6-hydroxydopamine on hypertension and noradrenaline content in the brain and heart of spontaneously hypertensive rats].
    Nikodijević O
    Acta Med Iugosl; 1975; 29(3):231-41. PubMed ID: 1146602
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W; Schömig A; Dietz R; Weber J; Gross F
    Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age differences in interrelationships between saline consumption, blood pressure and kidney weight in salt hypertension in the rat.
    Karen P; Havránek T; Jelínek J
    Physiol Bohemoslov; 1977 Aug; 26(4):315-23. PubMed ID: 144281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.